Literature DB >> 9351498

Potentiation by vasopressin of adrenergic vasoconstriction in the rat isolated mesenteric artery.

I Noguera1, P Medina, G Segarra, M C Martínez, M Aldasoro, J M Vila, S Lluch.   

Abstract

1. The aim of the present study was to investigate in rat mesenteric artery rings whether low concentrations of vasopressin could modify the contractile responses to noradrenaline and electrical stimulation of perivascular nerves. 2. Vasopressin (10[10]-10[-7] M) caused concentration-dependent contractions (pD2 = 8.36+/-0.09). The V1-receptor antagonist d(CH2)5Tyr(Me)AVP (10[-9]-10[-8] M) produced parallel rightward shifts of the control curve for vasopressin. Schild analysis yielded a pA2 value of 9.83 with a slope of 1.10+/-0.14. 3. Vasopressin (3 x 10[-10] and 10[-9] M) caused concentration-dependent potentiation of the contractions elicited by electrical stimulation (2-8 Hz; 0.2 ms duration for 30 s) and produced leftward shifts of the concentration-response curve for noradrenaline. The V1-receptor antagonist induced concentration-dependent inhibitions of potentiation induced by vasopressin. The selective V1-receptor agonist [Phe2, Orn8]-vasotocin (3 x 10[10] and 10[-9] M) induced potentiation of electrical stimulation-evoked responses which was also inhibited in the presence of the V1 antagonist (10[-8] M). In contrast, the V2-receptor agonist deamino-8-D-arginine vasopressin (desmopressin 10[-8]-10[-7] M) did not modify the electrical stimulation-induced responses and the V2-receptor antagonist [d(CH2)5, D-Ile2, Ile4, Arg8]-vasopressin (10[-8]-10[-7] M) did not affect the potentiation evoked by vasopressin. 4. In artery rings contracted by 10(-6) M noradrenaline in the presence of 10(-6) M guanethidine and 10(-6) M atropine, electrical stimulation (2, 4 and 8 Hz) produced frequency-dependent relaxations which were unaffected by 10(-9) M vasopressin but abolished by 10(-6) M tetrodotoxin. 5. Vasopressin also potentiated contractions elicited by KCl and contractions induced by addition of CaCl2 to KCl depolarized vessels. The augmenting effects were inhibited by the V1 antagonist. 6. In the presence of the calcium antagonist nifedipine (10[-6] M), vasopressin failed to enhance the contractile responses to electrical stimulation, noradrenaline and KCl. 7. The results demonstrate that low concentrations of vasopressin strongly potentiate the contractions to adrenergic stimulation and KCl depolarization. This effect appears to be mediated by V1 receptor stimulation which brings about an increase in calcium entry through dihydropyridine-sensitive calcium channels.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351498      PMCID: PMC1564956          DOI: 10.1038/sj.bjp.0701397

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  11 in total

1.  Effects of vasopressin on the sympathetic contraction of rabbit ear artery during cooling.

Authors:  A L García-Villalón; J Padilla; L Monge; N Fernández; M A Sánchez; B Gómez; G Diéguez
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

Review 2.  The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.

Authors:  Sascha Meyer; William McGuire; Sven Gottschling; Ghiath Mohammed Shamdeen; Ludwig Gortner
Journal:  Wien Med Wochenschr       Date:  2011-01-25

3.  The cellular mechanisms underlying the inhibitory effects of isoflurane and sevoflurane on arginine vasopressin-induced vasoconstriction.

Authors:  Manabu Shimogai; Koji Ogawa; Yasuyuki Tokinaga; Akinori Yamazaki; Yoshio Hatano
Journal:  J Anesth       Date:  2010-10-17       Impact factor: 2.078

Review 4.  Management of vasodilatory shock: defining the role of arginine vasopressin.

Authors:  Martin W Dunser; Volker Wenzel; Andreas J Mayr; Walter R Hasibeder
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Bench-to-bedside review: Vasopressin in the management of septic shock.

Authors:  James A Russell
Journal:  Crit Care       Date:  2011-08-11       Impact factor: 9.097

6.  Class A G protein-coupled receptors assemble into functional higher-order hetero-oligomers.

Authors:  Xianlong Gao; Garrett A Enten; Anthony J DeSantis; Matthias Majetschak
Journal:  FEBS Lett       Date:  2021-06-11       Impact factor: 3.864

Review 7.  Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

Review 8.  Inotropes for Preterm Infants: 50 Years on Are We Any Wiser?

Authors:  Aisling A Garvey; Elisabeth M W Kooi; Eugene M Dempsey
Journal:  Front Pediatr       Date:  2018-04-06       Impact factor: 3.418

9.  Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.

Authors:  Toonchai Indrambarya; John H Boyd; Yingjin Wang; Melissa McConechy; Keith R Walley
Journal:  Crit Care       Date:  2009-06-23       Impact factor: 9.097

Review 10.  Science review: Vasopressin and the cardiovascular system part 1--receptor physiology.

Authors:  Cheryl L Holmes; Donald W Landry; John T Granton
Journal:  Crit Care       Date:  2003-06-26       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.